SMMT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

SMMTSummit Therapeutics Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

SMMTSummit Therapeutics Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SMMT: latest quarter not drawable.Method ›

Price

rebased to 0%

SMMT, solidLLY, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SMMT 4

—Akeso, Inc. and its affiliates (collectively, "Akeso")unlistedsupplier

—Akesounlistedsupplier

—Gortecunlistedsupplier

—Dr. Zanganehunlistedcustomer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

SMMTSummit Therapeutics Inc.

16.01▼−1.15%· post 15.91

Mkt cap$12.8BRevenue—Revenue—

LLYELI Lilly & Co

1,412.87▲+2.85%· post 1,417.05

ClosedOct 30 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedOct 30 '26

SMMTSummit Therapeutics Inc.

LLYELI Lilly & Co

16.01▼−1.15%post 15.91

Price

1,412.87▲+2.85%post 1,417.05

$12.8B

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

SMMT16.01▼−1.15%vsLLY1,412.87▲+2.85%ClosedOct 30 '26